Resultados de la búsqueda 181 – 200 de 367
Table 2. Treatment of HIV-Associated Opportunistic Infections (Includes Recommendations for Acute Treatment and Secondary Prophylaxis/Chronic Suppressive/Maintenance Therapy)
Dolutegravir (Tivicay, DTG)
Special Considerations for Antiretroviral Therapy Use in Adolescents With HIV
Lactic Acidosis
Lamivudine
Protease Inhibitors (PIs)
Atazanavir
Tipranavir (Aptivus, TPV)
Special Populations: HIV-2 Infection
Appendix B: Leadership
Appendices
Appendix B. Important Guideline Considerations
Isosporiasis (Cystoisosporiasis)
Emtricitabine (Emtriva, FTC)
Entry and Attachment Inhibitors
Dolutegravir
Virologic Failure
Lopinavir/Ritonavir
Doravirine (Pifeltro, DOR)
Adverse Effects of Antiretroviral Agents